Nr 546 week 8 Study guides, Study notes & Summaries
Looking for the best study guides, study notes and summaries about Nr 546 week 8? On this page you'll find 151 study documents about Nr 546 week 8.
All 151 results
Sort by
-
NR 546 Advanced Psychopharmacology - ALL 8 weeks worth of Discussion Boards, Case Studies, MIDTERM QUESTIONS AND ANSWERS, FINAL EXAM STUDY GUIDE, ALL Medication Tables for each week, Neurotransmitter Table, and PowerPoint review for each week.
- Package deal • 25 items • 2023
-
- $75.49
- 8x sold
- + learn more
NR 546 Advanced Psychopharmacology
ALL 8 weeks worth of Discussion Boards, Case Studies, MIDTERM QUESTIONS AND ANSWERS, FINAL EXAM STUDY GUIDE, ALL Medication Tables for each week, Neurotransmitter Table, and PowerPoint review for each week. ALL the work for this entire class.
-
NR 546 WEEK 7 ADHD Medication Table (Updated)
- Exam (elaborations) • 3 pages • 2023 Popular
- Available in package deal
-
- $14.99
- 6x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) 
(Concerta, Ritalin) 
-Dopamine, norepinephrine 
inhibitor and releaser 
(DNRIRe), stimulant, FDA 
approved for ADHD in 
children and adults (ages vary 
based on formulations), 
narcolepsy. Off-label for 
treatmentresistant depression. 
Enhancement DA and NE in 
certain areas of the brain 
(dorsolateral prefrontal cortex, 
medial prefrontal cortex). 
Primary target symptoms: 
concentration, attention span, 
motor hyperactivity,...
-
NR 546 Week 8 Final Exam Study Guide from professor Filled Out
- Other • 35 pages • 2023
- Available in package deal
-
- $7.99
- 4x sold
- + learn more
Chamberlain NR 546 Week 8 Final Exam Study Guide from Professor Filled Out
-
NR 546 Week 8 Assignment; Neurotransmitter Table 2023/2024 | 100% Correct Verified
- Summary • 8 pages • 2023
- Available in package deal
-
- $10.49
- 1x sold
- + learn more
NR 546 Week 8 Assignment; Neurotransmitter Table 2023/2024 | 100% Correct Verified
-
NR 546 Week 8 Dementia Medication Table
- Other • 5 pages • 2023
- Available in package deal
-
- $7.99
- 2x sold
- + learn more
Chamberlain NR 546 Week 8 Dementia Medication Table
-
NR 546 Week 8 Neurotransmitter Table
- Other • 13 pages • 2023
- Available in package deal
-
- $7.99
- 1x sold
- + learn more
Chamberlain NR 546 Week 8 Neurotransmitter Table
-
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain
- Package deal • 4 items • 2023
-
- $20.49
- 1x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain

-
NR 546 Neurotransmitter Table completed Week 8 With Complete 2023 Solutions
- Case • 17 pages • 2022
-
- $14.99
- 8x sold
- + learn more
NR 546 Neurotransmitter Table completed Week 8 With Complete 2023 Solutions 
NR 546 Neurotransmitter Table completed Week 8 With Complete 2023 Solutions 
NR 546 Neurotransmitter Table completed Week 8 With Complete 2023 Solutions
-
NR 546 Week 8 Course Reflection 2023/2024 | 100% Correct Verified
- Other • 2 pages • 2024
-
- $9.39
- 1x sold
- + learn more
NR 546 Week 8 Course Reflection 2023/2024 | 100% Correct Verified
-
NR 546 Week 8 Course Reflection
- Other • 3 pages • 2022
- Available in package deal
-
- $20.49
- 12x sold
- + learn more
NR 546 Week 8 Course Reflection
-
NR 546 Week 7 ADHD Medication Table Latest.
- Other • 12 pages • 2023
- Available in package deal
-
- $12.99
- 3x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest. 
Drug Name 
(include if IR, XR, 
ODT, LA) 
 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, 
intermediate-acting or 
long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate 
(D/L) 
(Concerta, Ritalin) 
Indication (include 
approved ages) 
Attention deficit 
hyperactivity disorder 
(ADHD) in children and 
adults (approved ages vary 
base...